ARS Pharmaceuticals, Inc. (SPRY) Insider Trading

Name: ARS Pharmaceuticals, Inc. (SPRY) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 5, 2026): Donn Casale (President and CEO): Grant/Award of 1,036,923 shares.

Get alerted when insiders trade SPRY

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta